Stealth-Body Technology

Making Breakthrough Discoveries
with Stealth-Body Technology

Smart Cell Targeting

Stealth-Body

Proprietary Fc mutations that switch off effector function while leaving antigen binding intact.

Across the Fc gamma receptor panel, it shows no binding and no effector activity above background.

Effector engagement is one way an antibody acts on tissue it was never aimed at. Closing that route matters most when the antibody is carrying a payload.

Technology film

See how Stealth-Body works

3 min 24 sec · English subtitles

Mission

Key to the success of
novel drug development

CrossPoint Therapeutics strives to develop drugs that expands the range of curable disease as well as providing dignity and better life to patients.

More →
News & Media

In press media

Check out the latest news about our company below.

Read more →
Contact

Partnering and licensing inquiries.

Get in touch